114 related articles for article (PubMed ID: 2473353)
1. Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humans.
Shimamoto K; Nakagawa M; Fukuyama S; Ura N; Murakami H; Yonekura S; Iwakura M; Yamaguchi Y; Ise T; Saitoh S
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S59-62. PubMed ID: 2473353
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
Jespersen B; Pedersen EB
Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Klemm SA; Tunny TJ; Gordon RD
J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
[TBL] [Abstract][Full Text] [Related]
4. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
Zukowska-Grojec Z; Haass M; Kopin IJ; Zamir N
J Pharmacol Exp Ther; 1986 Nov; 239(2):480-7. PubMed ID: 2877083
[TBL] [Abstract][Full Text] [Related]
5. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.
Uehlinger DE; Weidmann P; Gnaedinger MP; Shaw S; Lang RE
J Clin Endocrinol Metab; 1986 Sep; 63(3):669-74. PubMed ID: 2942555
[TBL] [Abstract][Full Text] [Related]
6. Effects of human atrial natriuretic peptide on the pressor action of noradrenaline and angiotensin II in normal subjects.
Uehlinger DE; Weidmann P; Gnädinger MP; Shaw S
J Hypertens Suppl; 1985 Dec; 3(3):S319-21. PubMed ID: 2856727
[TBL] [Abstract][Full Text] [Related]
7. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic factor release during angiotensin II infusion in right and left atrial appendectomized rats.
Lachance D; Garcia R
J Hypertens; 1989 Apr; 7(4):293-8. PubMed ID: 2524525
[TBL] [Abstract][Full Text] [Related]
9. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
Schafferhans K; Heidbreder E; Hummel S; Heidland A
Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
[TBL] [Abstract][Full Text] [Related]
11. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
Cargill RI; Struthers AD; Lipworth BJ
Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
[TBL] [Abstract][Full Text] [Related]
12. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
[TBL] [Abstract][Full Text] [Related]
14. Effects of atrial natriuretic peptide, angiotensin II and III on norepinephrine uptake in the rat adrenal medulla.
Vatta MS; Bianciotti LG; Fernández BE
Rev Esp Fisiol; 1992 Sep; 48(3):185-9. PubMed ID: 1301634
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II, arginine-vasopressin, endothelin and catecholamines on plasma atrial natriuretic peptide concentrations in the conscious newborn calf.
Amadieu-Farmakis M; Davicco MJ; Giry J; Barlet JP
J Dev Physiol; 1991 Jul; 16(1):51-6. PubMed ID: 1838112
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of angiotensin II, atrial natriuretic peptide and their interaction in man.
McMurray JJ; Struthers AD
J Hypertens Suppl; 1987 Dec; 5(5):S59-62. PubMed ID: 2965232
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin and atrial natriuretic peptide on the cerebral circulation.
Tamaki K; Saku Y; Ogata J
J Cereb Blood Flow Metab; 1992 Mar; 12(2):318-25. PubMed ID: 1532178
[TBL] [Abstract][Full Text] [Related]
18. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
Doorenbos CJ; Blauw GJ; van Brummelen P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin.
Trippodo NC; MacPhee AA; Cole FE
J Hypertens Suppl; 1984 Dec; 2(3):S289-91. PubMed ID: 6242556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
